Vsee Health (NASDAQ:VSEE – Get Free Report) and GeneDx (NASDAQ:WGS – Get Free Report) are both computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership and valuation.
Analyst Ratings
This is a summary of recent recommendations for Vsee Health and GeneDx, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Vsee Health | 0 | 0 | 1 | 0 | 3.00 |
| GeneDx | 0 | 3 | 3 | 0 | 2.50 |
Vsee Health currently has a consensus target price of $5.00, indicating a potential upside of 244.83%. GeneDx has a consensus target price of $72.33, indicating a potential downside of 24.53%. Given Vsee Health’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Vsee Health is more favorable than GeneDx.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Vsee Health | $6.38 million | 0.82 | -$4.41 million | N/A | N/A |
| GeneDx | $305.45 million | 8.62 | -$175.77 million | ($1.96) | -48.90 |
Vsee Health has higher earnings, but lower revenue than GeneDx.
Profitability
This table compares Vsee Health and GeneDx’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Vsee Health | N/A | -182.59% | -58.26% |
| GeneDx | -17.12% | 3.33% | 1.69% |
Insider & Institutional Ownership
1.0% of Vsee Health shares are held by institutional investors. Comparatively, 61.7% of GeneDx shares are held by institutional investors. 6.6% of Vsee Health shares are held by insiders. Comparatively, 27.3% of GeneDx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
GeneDx beats Vsee Health on 7 of the 11 factors compared between the two stocks.
About Vsee Health
VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.
About GeneDx
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
Receive News & Ratings for Vsee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vsee Health and related companies with MarketBeat.com's FREE daily email newsletter.
